The scheme booklet was central to the application. The Court described it as setting out the terms of the schemes, their advantages and disadvantages, and annexing relevant associated documents. One of those documents was an independent expert report opining that the schemes were in the best interests of shareholders and option holders.
The Chairman’s Letter in the booklet summarised the reasons advanced in support of the restructure. Those reasons included positioning the group in the larger and deeper US capital market, facilitating access to a broader US investor pool, improving access to lower-cost US debt and equity capital markets, simplifying the group’s corporate structure for a potential future US merger, positioning the group for a potential US IPO, and mitigating foreign control concerns in pursuing classified contracts with the US government.
The booklet also identified disadvantages. The Court specifically referred to potential taxation consequences, the uncertain trading value of the CDIs, exposure to increased litigation risk, and the consequences of replacing a direct equity interest in an Australian company with a CDI or option position in a foreign company. Those matters were also considered in the independent expert report.
This balanced treatment mattered. The Court repeated the established principle that members should be allowed to make the commercial decision themselves, provided they have sufficient information and time. That is why the Court focused on whether the booklet gave proper disclosure rather than trying to decide the commercial merits in place of investors.
The evidence before the Court included affidavits from Amaero’s solicitors and chief financial officer, company searches, ASIC lodgement confirmation for the draft booklet, correspondence with ASIC and the ASX, and evidence about due diligence and verification of the booklet. The reasons show a conventional but detailed evidentiary foundation for a first-hearing scheme application.